ImmunoACT
Pioneer's of CAR-T Cell Therapy Made in India Developers of NexCAR19™ Committed to Accessible, Affordable, Life-saving Innovations
Instagram
Instagram
YouTube
YouTube
X
X
Video
CAR-T in India: Challenges, Learnings, and Future Potential – Dr. Esha Kaul
CAR-T in India: Challenges, Learnings, and Future Potential – Dr. Esha Kaul
Dr. Esha Kaul, Senior Hematologist, shares her valuable experience and perspectives on CAR-T cell therapy in India.In this conversation, she discusses:Counse...
YouTube
YouTube
Share your videos with friends, family, and the world
X
X
ImmunoACT - India's Pioneer in Cell & Gene Therapies
ImmunoACT - India's Pioneer in Cell & Gene Therapies
ImmunoACT | LinkedIn
ImmunoACT | LinkedIn
ImmunoACT | 34,623 followers on LinkedIn. India's Leader in Cell & Gene Therapies | Spun-out from IIT-Bombay in 2018, ImmunoACT is India's pioneer of Gene-modified Cell Therapies, having launched the country's first CAR-T cell therapy for treatment of certain B-cell malignancies. With a rapidly expanding pipeline beginning, our mission is to provide affordable access to novel CAR-T cell therapies.
View on mobile
